This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_CERVIX_UTERI_NOS_EXALLC for full statistics.
Carcinoma in situ of uteri, other/unspecified
CD2_INSITU_CERVIX_UTERI_NOS
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
227 |
4. Check minimum number of eventsNone |
227 |
5. Include endpointsNone |
227 |
6. Filter based on genotype QC (FinnGen only) |
227 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of uteri, other/unspecified
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of uteri, other/unspecified
- HSIL lesion of the cervix uteri
- HSIL lesion of the cervix uteri, vagina or vulva
- All dysplastic lesions of the cervix uteri
- All dysplastic lesions of the cervix uteri, vagina or vulva
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 227 | 227 | - |
| Unadjusted period prevalence (%) | 0.08 | 0.08 | - |
| Median age at first event (years) | 35.79 | 35.79 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 212
- Matched controls
- 2118
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8070/2-C53.9
ICD-O-3
Squamous cell carcinoma in situ, NOS, of cervix uteri
594.3
160.9
141
7
D06.9
ICD-10 Finland
Carcinoma in situ: Cervix, unspecified
+∞
138.1
117
*
2331A
ICD-9 Finland
Carcinoma in situ of breast and genito-urinary system, Cervix uteri
+∞
109.0
95
*
8326
FHL
Batch conization
415.6
63.0
60
*
D06.0
ICD-10 Finland
Carcinoma in situ: Endocervix
194.3
32.7
33
*
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
10.5
30.6
64
84
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
6.9
29.8
87
193
ULA02
NOMESCO Finland
Kolposcopy
6.6
29.2
89
208
N87.2
ICD-10 Finland
Severe cervical dysplasia, not elsewhere classified
14.7
23.5
40
33
LDA10
NOMESCO Finland
Curettage of cervix uteri
7.4
19.0
48
81
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
4.5
18.7
80
253
D06.1
ICD-10 Finland
Carcinoma in situ: Exocervix
43.9
16.6
20
5
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
5.0
15.2
53
133
LDC00
NOMESCO Finland
Conisation of cervix uteri using knife
+∞
14.8
14
*
8140/2-C53.9
ICD-O-3
Adenocarcinoma in situ, NOS, of cervix uteri
+∞
13.7
13
*
D06.7
ICD-10 Finland
Carcinoma in situ: Other parts of cervix
+∞
8.4
8
*
8077/2-C53.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of cervix uteri
7.6
7.6
17
24
8076/3-C53.9
ICD-O-3
Squamous cell carcinoma, microinvasive of cervix uteri
82.9
7.5
8
*
8070/3-C53.9
ICD-O-3
Squamous cell carcinoma, NOS, of cervix uteri
41.4
6.8
8
*
ZXC00
NOMESCO Finland
Use of diathermy
13.0
6.1
10
8
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3025130) Human papilloma virus identified in Specimen
15
38
4.16
5.53
2.3
1.9
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
12
31
4.03
4.31
1.2
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
75
525
1.64
2.94
2.0
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
22
104
2.24
2.85
2.2
1.3
—
—
—
0
0
(4034850)
15
60
2.61
2.76
9.7
5.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
79
571
1.59
2.68
1.8
2.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
0
57
0.00
2.08
0.0
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
13
57
2.36
2.02
1.3
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
13
57
2.36
2.02
1.3
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
13
57
2.36
2.02
1.3
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
13
57
2.36
2.02
1.3
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
17
84
2.11
2.01
8.2
2.9
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
11
4.62
1.95
5.8
6.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
27
428
0.58
1.91
1.2
1.3
g/l
1.9
2.1
0.93
18
261
(3011397) Hemoglobin [Presence] in Urine by Test strip
60
438
1.50
1.88
3.2
3.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
10
214
0.44
1.79
2.5
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
12
231
0.49
1.61
4.2
4.1
%
28.7
33.7
—
7
156
(40761535) Cells panel - Urine sediment
25
155
1.69
1.54
3.1
3.4
—
—
—
0
0
(44813793)
5
15
3.38
1.53
1.0
1.0
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
177
1902
0.68
1.49
5.4
5.1
mu/l
1.7
2.4
0.59
169
1775
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
134
1502
0.74
1.43
7.2
6.9
u/l
77.5
77.0
0.06
129
1402
(3019225) pH of Specimen
8
165
0.47
1.42
3.9
3.9
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
16
90
1.84
1.37
1.8
1.8
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
33
227
1.53
1.36
1.6
1.5
%
1.3
1.3
0.02
28
198
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
0
40
0.00
1.34
0.0
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
35
483
0.67
1.33
1.3
1.3
u/ml
2.1
2.1
0.00
11
138
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
21
130
1.68
1.32
1.5
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
9
43
2.14
1.32
1.3
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
56
706
0.73
1.27
1.9
1.8
pmol/l
91.7
100.5
0.92
30
342
(36660697) Celiac disease serology panel - Serum
9
169
0.51
1.24
1.1
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
168
1806
0.73
1.22
12.6
12.5
%
38.7
39.6
0.72
134
1397
(3020630) Protein [Mass/volume] in Serum or Plasma
6
127
0.46
1.21
4.3
2.1
g/l
67.3
67.4
—
6
118
(1761482) Bacteria [#/volume] in Urine by Culture
8
38
2.14
1.19
5.5
3.7
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
0
33
0.00
1.17
0.0
5.9
—
40.8
—
0
28
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
0
33
0.00
1.17
0.0
5.9
—
20.8
—
0
27
(3004616) Nuclear Ab [Presence] in Serum
0
33
0.00
1.17
0.0
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
0
36
0.00
1.15
0.0
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
0
36
0.00
1.15
0.0
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
30
2.37
1.13
1.3
2.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
186
1963
0.71
1.13
11.2
11.5
mg/l
18.6
19.3
0.12
146
1496
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
19
287
0.63
1.11
2.1
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
10
177
0.54
1.07
2.7
1.8
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
22
314
0.67
1.00
1.8
1.3
titre
275.6
485.8
—
9
69
(3007853) Bacteria identified in Skin by Aerobe culture
27
192
1.46
0.98
1.6
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
181
1910
0.74
0.98
4.2
4.2
mmol/l
5.9
5.7
0.67
169
1787
(3021788) Differential panel - Synovial fluid
0
30
0.00
0.98
0.0
1.6
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
79
918
0.79
0.95
5.8
5.6
%
30.1
29.3
0.24
74
855
(3019198) Lymphocytes [#/volume] in Blood
85
979
0.79
0.94
6.6
5.6
e9/l
2.0
1.9
0.26
78
870
(3016879) Cocaine [Presence] in Urine
9
52
1.76
0.93
1.3
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
45
560
0.76
0.91
5.8
3.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
6
30
2.03
0.87
1.0
1.0
—
0.3
—
0
7
(3015736) pH of Urine
88
763
1.25
0.86
4.1
3.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
75
639
1.26
0.86
3.1
3.1
ng/l
196.0
20.2
0.79
34
378
(3038515) Glucose [Moles/volume] in Venous blood
6
31
1.96
0.85
3.7
2.5
mmol/l
7.7
7.5
—
6
31
(3020564) Creatinine [Moles/volume] in Serum or Plasma
201
2080
0.71
0.83
13.7
13.2
umol/l
67.1
67.7
0.24
201
2080
(3013139) Helicobacter pylori Ag [Presence] in Stool
20
140
1.47
0.80
1.5
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
34
432
0.75
0.80
1.6
1.5
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
6
33
1.84
0.79
3.7
2.5
mmol/l
1.4
1.3
—
6
33
(40760888) Immunoglobulin light chains.free panel - Serum
0
25
0.00
0.79
0.0
6.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
51
613
0.78
0.79
5.9
5.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
0
27
0.00
0.78
0.0
1.9
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
85
963
0.81
0.77
6.0
5.6
e9/l
0.0
0.0
0.21
76
832
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
11
67
1.67
0.76
4.5
3.1
%
48.1
46.0
0.09
11
67
(3023103) Potassium [Moles/volume] in Serum or Plasma
191
1987
0.76
0.76
12.2
12.4
mmol/l
3.9
3.9
0.31
186
1933
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
22
160
1.42
0.73
9.4
5.1
u/l
233.4
245.9
0.28
22
150
(3020891) Body temperature
9
56
1.63
0.73
6.3
4.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
172
1809
0.80
0.72
5.3
5.0
mmol/mol
39.0
38.6
0.23
161
1700
(3001604) Monocytes [#/volume] in Blood
85
957
0.82
0.72
5.8
5.6
e9/l
0.5
0.5
0.23
76
831
(3012544) pH of Venous blood
19
135
1.44
0.71
3.4
2.8
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
191
1984
0.76
0.71
12.1
12.3
mmol/l
139.8
139.9
0.13
186
1932
(3028026) IgM [Mass/volume] in Serum or Plasma
7
120
0.57
0.69
1.0
1.6
g/l
1.5
1.5
—
7
109
(3013115) Eosinophils [#/volume] in Blood
90
1004
0.83
0.68
5.8
5.9
e9/l
0.2
0.2
1.54
80
893
(3014051) Protein [Presence] in Urine by Test strip
7
44
1.61
0.65
2.3
2.0
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
18
130
1.42
0.63
3.3
2.9
mmol/l
3.0
2.5
0.25
12
106
(3013707) Erythrocyte sedimentation rate by Westergren method
140
1494
0.84
0.62
3.8
4.0
mm/h
11.6
10.6
0.42
134
1378
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
9
141
0.62
0.62
2.3
3.1
ng/l
48.8
71.9
—
9
125
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.2
—
72.2
—
0
5
(3032773) Endomysium IgG Ab [Titer] in Serum
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
13
184
0.69
0.59
1.1
1.3
iu/ml
168.7
153.2
—
7
85
(3050129) First trimester maternal screen panel - Serum or Plasma
8
53
1.53
0.59
1.6
1.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
20
150
1.37
0.58
5.3
3.3
pmol/l
4.6
4.6
0.08
20
133
(3045424) Erythrocytes [Presence] in Urine
6
35
1.73
0.58
1.5
1.6
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
5
86
0.57
0.57
1.0
2.6
u/l
36.8
41.3
—
5
78
(3005719) IgG [Mass/volume] in Serum or Plasma
10
147
0.67
0.55
1.2
2.5
g/l
10.9
10.0
—
10
137
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
129
1379
0.85
0.55
2.9
3.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
33
269
1.27
0.55
3.3
2.4
e6/l
1.1
1.1
0.05
23
140
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
48
410
1.22
0.54
1.2
1.3
iu/ml
28.6
31.8
0.09
21
139
(3021879) Hepatitis B virus core Ab [Presence] in Serum
9
132
0.67
0.53
2.2
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
9
133
0.66
0.53
1.8
1.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
14
191
0.72
0.53
4.4
4.2
mmol/l
1.0
1.1
0.13
14
172
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
17
126
1.38
0.53
1.2
1.5
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
112
1032
1.17
0.53
3.1
3.9
mmol/l
6.6
6.4
0.52
106
958
(3037467) Urinalysis macro (dipstick) panel - Urine
125
1337
0.86
0.53
4.7
4.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
28
225
1.28
0.52
1.7
1.8
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
103
1117
0.86
0.52
10.4
9.3
e9/l
3.9
3.9
0.14
92
971
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
21
163
1.32
0.50
1.4
1.4
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
12
84
1.45
0.50
4.1
8.4
%
91.9
94.9
1.06
12
84
(3021601) Nitrite [Presence] in Urine by Test strip
106
978
1.16
0.48
6.8
4.8
estimate
0.0
0.0
0.00
16
188
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
12
165
0.71
0.48
2.4
3.0
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
12
165
0.71
0.48
2.4
2.4
—
9.6
—
0
5
(1761868) Lipid panel - Serum or Plasma
86
782
1.16
0.47
2.7
2.7
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
34
402
0.82
0.46
1.4
1.4
nmol/l
22.3
22.5
0.02
29
330
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
49
558
0.84
0.45
1.5
1.7
mmol/l
1.5
1.4
0.30
41
475
(3028707) Methadone [Presence] in Urine by Screen method
5
31
1.63
0.43
1.4
1.4
—
—
—
0
0
(1002224) Polysomnography panel
6
94
0.63
0.43
1.3
1.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
106
986
1.14
0.42
4.6
3.5
estimate
0.0
0.0
0.80
15
184
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
158
1647
0.87
0.42
4.4
4.4
pmol/l
14.8
14.5
0.61
149
1529
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
15
0.00
0.41
0.0
1.1
—
33.0
—
0
15
(3017354) Segmented neutrophils/100 leukocytes in Blood
0
15
0.00
0.41
0.0
2.7
—
51.9
—
0
8
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
0
16
0.00
0.41
0.0
1.8
—
42.5
—
0
11
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
96
888
1.14
0.41
3.7
3.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
12
88
1.38
0.41
1.1
1.6
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
52
584
0.86
0.40
2.8
2.2
u/l
49.6
56.7
1.11
46
540
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
7
101
0.68
0.40
1.9
1.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
18
0.00
0.40
0.0
2.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
182
1876
0.85
0.40
11.0
10.5
ml/min/173m2
84.2
84.3
0.01
152
1527
(3005570) Glucose [Moles/volume] in Urine
0
19
0.00
0.39
0.0
3.8
—
—
—
0
0
(3044889) 12 lead EKG panel
142
1351
1.14
0.38
3.2
3.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
58
520
1.15
0.38
1.4
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
19
234
0.79
0.38
1.2
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
205
2090
0.80
0.37
9.6
9.8
u/l
26.7
24.3
0.29
199
2030
(3018095) Leukocytes [#/volume] in Urine
69
628
1.14
0.37
3.5
3.2
e6/l
9.9
61.2
3.99
51
415
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
76
0.65
0.36
9.8
2.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
5
78
0.63
0.36
1.0
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
12
156
0.76
0.36
3.1
3.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
29
247
1.20
0.35
3.8
2.6
e6/l
5.6
4.0
0.44
19
118
(3020682) Albumin/Creatinine [Ratio] in Urine
56
506
1.14
0.33
4.2
3.6
mg/mmol
3.9
8.1
0.79
34
285
(3009343) pH of Capillary blood
6
86
0.69
0.33
3.5
3.3
—
7.4
—
0
14
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
6
88
0.67
0.33
3.5
3.3
kpa
5.3
5.3
—
6
81
(40768804) Tissue Pathology biopsy report
92
859
1.12
0.33
2.1
2.0
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
57
517
1.14
0.32
2.5
2.7
mmol/l
6.3
6.9
0.41
52
431
(3022621) pH of Urine by Test strip
15
120
1.27
0.31
5.3
2.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
21
249
0.83
0.31
2.0
1.9
—
—
—
0
0
(3008898) HLA-B27 [Presence]
8
107
0.74
0.29
1.0
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
25
289
0.85
0.28
1.5
1.6
nmol/l
1343.0
1178.2
0.40
20
214
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
26
225
1.18
0.27
1.9
1.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
48
436
1.13
0.27
2.0
2.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
41
454
0.88
0.27
3.5
1.7
mg/l
1.3
0.9
0.44
34
359
(3032080) INR in Blood by Coagulation assay
60
648
0.90
0.26
10.0
5.5
inr
1.1
1.1
0.26
23
208
(3000492) Spirometry study
21
180
1.18
0.25
1.2
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
19
222
0.84
0.24
2.6
1.9
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
9
77
1.18
0.24
4.2
2.1
%
1.3
1.1
—
9
77
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
6
81
0.73
0.24
3.8
5.7
mmol/l
24.5
25.5
—
6
81
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
6
84
0.71
0.24
1.0
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
6
85
0.70
0.24
1.0
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
5
38
1.32
0.23
1.2
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
12
98
1.24
0.21
1.1
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
2.4
—
0
11
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
11
0.00
0.21
0.0
1.7
—
11.4
—
0
11
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
9.1
—
0
10
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
88.2
—
0
10
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
12
0.00
0.21
0.0
1.5
—
99.7
—
0
12
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.1
—
56.2
—
0
8
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
13
0.00
0.21
0.0
3.8
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
13
0.00
0.21
0.0
4.3
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
13
0.00
0.21
0.0
3.7
—
15.6
—
0
13
(3011412) CD3 cells [#/volume] in Blood
0
13
0.00
0.21
0.0
1.2
—
1.5
—
0
5
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.1
—
9.4
—
0
8
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
12
144
0.82
0.20
1.2
1.3
—
33.9
—
0
6
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.1
—
17.7
—
0
14
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.4
—
1.0
—
0
14
(4027681)
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.0
—
1.3
—
0
6
(3027945) Reticulocytes/100 erythrocytes in Blood
17
146
1.18
0.20
2.2
3.3
%
1.8
1.8
0.08
17
131
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
74
780
0.92
0.19
5.2
3.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
6
52
1.16
0.19
1.5
1.5
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
20
176
1.15
0.18
4.5
6.0
mmol/l
104.5
104.0
0.24
20
169
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
93
893
1.07
0.17
4.5
5.9
mmol/l
1.2
1.2
0.38
81
759
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
19
168
1.14
0.16
1.3
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
19
168
1.14
0.16
1.2
1.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
18
203
0.88
0.16
2.3
1.8
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
80
0.74
0.15
1.8
1.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
9
80
1.13
0.15
1.7
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
21
233
0.89
0.15
1.4
1.3
—
—
—
0
0
(4010399)
12
139
0.86
0.14
1.3
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
12
139
0.86
0.14
5.8
4.8
—
0.2
—
0
26
(46235355) HIV 1 and 2 tests - Meaningful Use set
29
315
0.91
0.14
2.1
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
24
218
1.11
0.14
1.1
1.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
83
861
0.94
0.13
7.7
8.3
e9/l
0.0
0.0
0.72
72
700
(4035726)
16
179
0.89
0.12
1.9
1.3
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
53
557
0.94
0.12
2.0
2.0
u/l
171.8
128.8
0.32
53
531
(3000850) Epithelial cells [#/volume] in Urine
33
353
0.92
0.12
1.8
2.3
e6/l
2.5
6.7
5.33
27
317
(3035350) Ketones [Presence] in Urine by Test strip
100
972
1.05
0.11
4.1
3.5
estimate
0.0
0.0
0.00
14
187
(3026008) Bacteria identified in Urine by Culture
60
575
1.06
0.11
3.1
2.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
204
2058
0.91
0.10
10.9
10.8
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
44
462
0.94
0.10
2.3
2.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
195
1969
0.93
0.10
4.0
4.3
mmol/l
5.0
5.0
0.18
185
1862
(3052851) Hemolysis interference index of Serum or Plasma
5
48
1.04
0.09
1.6
2.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
22
237
0.92
0.09
1.1
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
46
480
0.95
0.09
2.7
2.9
mg/l
17.2
338.4
0.87
26
279
(3022313) Gas panel - Capillary blood
6
58
1.04
0.08
2.7
3.6
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
5
63
0.79
0.08
1.8
1.6
mu/l
212.2
260.6
—
5
55
(42529406) Shigella sp [Presence] in Stool by Culture
6
71
0.84
0.08
1.8
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
6
70
0.85
0.08
1.8
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
70
0.85
0.08
1.8
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
76
1.05
0.07
1.8
1.9
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
55
532
1.04
0.07
3.6
3.7
estimate
0.0
0.0
0.00
16
189
(3025941) Bacteria identified in Stool by Culture
13
118
1.11
0.07
1.5
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
10
89
1.13
0.07
4.0
4.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
8
93
0.86
0.07
2.5
2.4
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
8
95
0.84
0.07
8.6
6.3
mmol/l
26.5
25.3
—
8
90
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
24
254
0.94
0.06
1.3
1.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
198
1994
0.95
0.06
4.5
4.7
mmol/l
3.0
3.0
0.07
186
1868
(40758558) Short blood count panel - Blood
51
495
1.04
0.05
5.8
7.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
10
110
0.90
0.05
4.6
7.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
189
1878
1.04
0.04
3.5
3.8
mmol/l
1.3
1.2
0.36
174
1759
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
43
418
1.04
0.04
1.3
1.3
u/ml
34.8
10.8
0.50
14
176
(3023368) Bacteria identified in Blood by Culture
37
381
0.97
0.03
3.0
3.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
62
610
1.02
0.02
3.3
2.8
—
—
—
0
0
(3026782) Osmolality of Urine
34
331
1.03
0.02
4.5
2.3
mosm/kgh2o
489.7
519.5
0.37
29
284
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
15
158
0.95
0.02
1.4
2.2
g/l
0.2
0.2
0.41
15
153
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
18
172
1.05
0.02
2.3
2.5
ml/min/173m2
66.4
71.5
—
8
68
(40760892) CBC W Ordered Manual Differential panel - Blood
48
471
1.02
0.02
5.3
4.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
24
233
1.03
0.01
5.0
5.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
195
1957
0.97
0.01
3.8
4.2
mmol/l
1.6
1.6
0.74
184
1839
(3019832) Treponema pallidum Ab [Presence] in Serum
16
158
1.01
0.00
1.6
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
29
286
1.02
0.00
1.1
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
32
319
1.00
0.00
2.5
3.4
ng/l
51.3
318.9
0.68
18
215
(3018418) pH of Serum or Plasma
57
571
1.00
0.00
2.2
3.6
ph
7.4
7.4
—
8
106
(3013512) EKG study
51
509
1.00
0.00
3.8
3.2
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
16
163
0.98
0.00
3.6
7.0
kpa
5.4
5.2
0.61
16
158
(3027801) Oxygen [Partial pressure] in Arterial blood
16
163
0.98
0.00
3.6
7.0
kpa
11.1
12.4
0.53
16
158
(3030467) Casts [#/volume] in Urine by Automated count
46
463
0.99
0.00
3.3
2.8
e6/l
0.2
0.5
1.62
36
341
(3003338) MCHC [Mass/volume]
170
1697
1.01
0.00
16.2
15.2
g/l
331.6
330.9
0.44
170
1688
(3002582) Erythrocytes [#/volume] in Urine
50
502
0.99
0.00
3.3
2.8
e6/l
11.3
72.7
1.30
41
377
(3018677) aPTT in Platelet poor plasma by Coagulation assay
23
235
0.98
0.00
2.7
1.8
s
29.0
29.7
0.26
23
224
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
53
0.94
0.00
1.8
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
5
51
0.98
0.00
4.6
2.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
30.8
—
0
6
(3002619) Bacteria identified in Specimen by Culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
0
5
0.00
0.00
0.0
1.2
—
5.9
—
0
5
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
49
1.02
0.00
1.8
1.5
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
80.2
—
0
7
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
8
0.00
0.00
0.0
3.8
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
49
1.02
0.00
1.8
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
49
1.02
0.00
1.8
1.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
1.7
—
0
6
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
9
0.00
0.00
0.0
2.1
—
63.5
—
0
9
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
7
0.00
0.00
0.0
10.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.0
—
199.0
—
0
6
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019977) pH of Arterial blood
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
2.4
—
0
6
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002256) Pathology report gross observation
27
270
1.00
0.00
1.3
1.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806420)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
7
70
1.00
0.00
2.6
2.7
u/ml
8.0
1878.5
—
7
63
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
12.5
—
0
6
(3000012) Reticulocyte production index
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
0
7
0.00
0.00
0.0
1.1
—
0.3
—
0
7
(3035880) pH of Pleural fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
5
0.00
0.00
0.0
1.6
—
4.5
—
0
5
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
95.0
—
0
7
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
15.2
—
0
6
(3009871) Measles virus Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
49
1.02
0.00
1.8
1.5
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
6
0.00
0.00
0.0
4.7
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004451) EKG impression Narrative
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
0
6
0.00
0.00
0.0
34.8
—
109.0
—
0
6
(3001186) Copper [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
17.3
—
0
5
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
9
0.00
0.00
0.0
3.7
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
52
0.96
0.00
1.6
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
2217.0
—
0
5
(3017704) Immunofixation for Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
55
0.91
0.00
1.6
1.3
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
76.8
—
0
5
(3047189) Immunofixation for 24 hour Urine
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
5
55
0.91
0.00
1.6
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_CERVIX_UTERI_NOS – Carcinoma in situ of uteri, other/unspecified
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).